CTLA4-Ig mediated immunosuppression favors immunotolerance and restores graft in mouse airway transplants-Reference-Cited by-同舟云学术

CTLA4-Ig mediated immunosuppression favors immunotolerance and restores graft in mouse airway transplants

Published:2022-04 Issue: Volume:178 Page:106147
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Khan Mohammad Afzal,Shamma Talal,Altuhami Abdullah,Ahmed Hala Abdalrahman,Assiri Abdullah Mohammed,Broering Dieter Clemens

Publisher

Elsevier BV

Subject

Pharmacology

Reference77 articles.

1. CTLA4-Ig: a novel immunosuppressive agent;Najafian;Expert Opin. Investig. Drugs,2000

2. CTLA4-Ig: progress with a novel immunosuppressive agent in experimental solid organ transplantation;Pagani;BioDrugs Clin. Immunother. Biopharm. Gene Ther.,1997

3. CTLA4Ig: bridging the basic immunology with clinical application;Bluestone;Immunity,2006

4. Complement factor and T-cell interactions during alloimmune inflammation in transplantation;Khan;J. Leukoc. Biol.,2019

5. The immunosuppressive effect of CTLA4 immunoglobulin is dependent on regulatory T cells at low but not high doses;Schwarz;Am. J. Transpl.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring regulatory T cells as a prognostic marker in lung transplantation;Frontiers in Immunology;2023-09-25

2. Drug therapy for myocarditis induced by immune checkpoint inhibitors;Frontiers in Pharmacology;2023-05-25

3. CTLA4-Ig alleviates the allogeneic immune responses against insulin-producing cells in a murine model of cell transplantation;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-05-25

4. Facing challenges with hope: universal immune cells for hematologic malignancies;Cancer Biology & Medicine;2023-05-04